CITIC Capital Partners has appointed Haipeng Zhang as a senior managing director, with the intent of focusing on healthcare investments.
Chinese healthcare services provider iKang Healthcare Group has accepted a take-private offer from its founder in collaboration with FountainVest Partners.
IHH Healthcare has agreed to buy India's Ravindranath GE Medical (RGE), which operates five hospitals under the Global Hospitals brand, for INR12.8 billion ($194 million) in cash.
Chinese drug maker Shanghai Pharmaceuticals Group has partnered with Shanghai Real Power Capital to launch a healthcare-focused fund with a target of RMB3 billion ($469 million).
Chinese online retailer JD.com and IDG Capital Partners have participated in a RMB1.11 billion ($174 million) Series A round of funding for Shanghai Pharmaceuticals’ online drug distribution platform.
Burning Rock Biotech, a Chinese cancer diagnostic start-up, has raised RMB150 million ($23 million) in an extended Series A round of funding from Ji Feng Capital, Sequoia Capital and Legend Star.
Ascentage Pharma Group, a Shanghai-based cancer drug developer, has raised a RMB95 million ($15 million) Series A round of funding led by Oriza Seed and YuanMing Capital.
CASH Capital, the venture capital arm of the state-owned Chinese Academy of Sciences Holdings (CASH Holdings), is seeking to raise RMB1.2 billion ($193 million) for its second renminbi-denominated venture fund.
Shanghai-listed Nanjing Xinjiekou Department Store has made a bid to acquire China Cord Blood Corporation (CCBC), a US-listed blood bank operator backed by KKR, for about RMB6 billion ($966 million).
Tencent has led a $90 million Series C round for Indian clinic management developer and doctor search portal Practo, with participation from Sofina, Google Capital, and others.
Shanghai KingYee, a Chinese mobile healthcare services provider, has completed a RMB221 million ($36 million) Series C round of funding led by Sensegain Investment. SoftBank China Venture Capital (SBCVC) and HighLight Capital also participated.
China-based Hopu Investments and YuanMing Capital have led a $200 million investment in US-based cancer treatment specialist Mevion Medical Systems.
The Riverside Company has acquired in IPAR Rehabilitation, an Australia-based provider of injury prevention and management and rehabilitation services that minimize the impact of workplace injury and illness.
HealthCare Global Enterprises (HCG), a private equity-backed Indian cancer care hospital chain, has filed for an IPO.
India's vast assortment of ethnic groups represents a golden opportunity for MedGenome. The 2,000 groups that inhabit the subcontinent are a treasure trove of information waiting to be harvested and put to work.
GSR Capital and its affiliate Go Scale Capital has raised $1 billion for a cross-border buyout and M&A fund, which it hopes will translate into $5 billion worth of dry powder once debt financing and co-investment are factored in.
GGV Capital has led an extended Series A round of funding for Ypzdw.com, a Chinese online B2B drug retail platform. Existing investor Matrix Partners China also participated.
Sequoia Capital has committed $20 million in Series B funding to Indian genomic diagnostic and research service provider MedGenome.
Healthcare specialist Vivo Capital has led a Series B round of funding for Gengmei, a Chinese cosmetic surgery social networking app, with participation from Sequoia Capital.
KKR has completed its second social enterprise assistance project alongside Impact Investment Exchange Asia (IIX) and its non-profit sister organization Shujog, providing support to Glovax Biotech, which sells affordable vaccines to low to middle income...
FountainVest Partners has led a RMB200 million ($32 million) round of funding for Xingren.com, a Chinese mobile app for doctors to communicate with patients. Existing investors Sequoia Capital and Lightspeed China Partners also participated.
Tiger Global has led a $10.2 million Series B round investment in Indian doctor search app Lybrate.
US early stage investor Founders Fund and Japanese conglomerate Mitsui & Co have together invested JPY620 million ($5.1 million) in Genesis Healthcare, a Tokyo-based start-up that develops genetic testing kits, in exchange for a 6% stake.
Cathay Capital Private Equity has invested an undisclosed sum in Cenexi Group, a French pharmaceutical contract manufacturer.